Royal Bank of Canada’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.68M | Buy |
189,551
+186,471
| +6,054% | +$7.55M | ﹤0.01% | 2026 |
|
|
2025
Q1 | $158K | Sell |
3,080
-404
| -12% | -$20.7K | ﹤0.01% | 4532 |
|
|
2024
Q4 | $194K | Sell |
3,484
-3,199
| -48% | -$178K | ﹤0.01% | 4391 |
|
|
2024
Q3 | $220K | Buy |
6,683
+438
| +7% | +$14.4K | ﹤0.01% | 4310 |
|
|
2024
Q2 | $170K | Buy |
6,245
+2,975
| +91% | +$81K | ﹤0.01% | 4511 |
|
|
2024
Q1 | $119K | Sell |
3,270
-9,944
| -75% | -$362K | ﹤0.01% | 4650 |
|
|
2023
Q4 | $267K | Buy |
13,214
+6,931
| +110% | +$140K | ﹤0.01% | 4334 |
|
|
2023
Q3 | $111K | Buy |
6,283
+3,466
| +123% | +$61.2K | ﹤0.01% | 4836 |
|
|
2023
Q2 | $50K | Buy |
2,817
+1,548
| +122% | +$27.5K | ﹤0.01% | 5337 |
|
|
2023
Q1 | $16K | Sell |
1,269
-1,684
| -57% | -$21.2K | ﹤0.01% | 5731 |
|
|
2022
Q4 | $43K | Buy |
2,953
+2,510
| +567% | +$36.5K | ﹤0.01% | 5507 |
|
|
2022
Q3 | $8K | Buy |
443
+121
| +38% | +$2.19K | ﹤0.01% | 6058 |
|
|
2022
Q2 | $4K | Sell |
322
-415
| -56% | -$5.16K | ﹤0.01% | 6289 |
|
|
2022
Q1 | $13K | Sell |
737
-1,410
| -66% | -$24.9K | ﹤0.01% | 6353 |
|
|
2021
Q4 | $49K | Buy |
2,147
+1,222
| +132% | +$27.9K | ﹤0.01% | 5856 |
|
|
2021
Q3 | $20K | Buy |
925
+348
| +60% | +$7.52K | ﹤0.01% | 6187 |
|
|
2021
Q2 | $17K | Sell |
577
-893
| -61% | -$26.3K | ﹤0.01% | 6149 |
|
|
2021
Q1 | $48K | Buy |
1,470
+645
| +78% | +$21.1K | ﹤0.01% | 5422 |
|
|
2020
Q4 | $34K | Buy |
+825
| New | +$34K | ﹤0.01% | 5274 |
|